Skip to content

Radiology Rewired | Conversations that move radiology forward
Catch up on season 1 before the new season drops

Tune in
  • There are no suggestions because the search field is empty.
  • There are no suggestions because the search field is empty.
Press Release

RapidAI Receives FDA Clearance for Rapid Hyperdensity

RapidAI announced it has received FDA clearance for Rapid Hyperdensity, the newest addition to the RapidAI platform

Share to

RapidAI announced it has received FDA clearance for Rapid Hyperdensity, the newest addition to the RapidAI platform

San Mateo, Calif. — July 21 , 2022 — RapidAI , the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA clearance for Rapid Hyperdensity , the newest addition to the RapidAI platform. The tool empowers physicians to quickly assess the severity of injury in patients with acute neuro conditions such as traumatic brain injury and brain hemorrhages – allowing for better and faster patient care decisions. Powered by AI, Rapid Hyperdensity uses non-contrast CT scans to quickly assess the volume of hyperdense tissue in the brain to help physicians identify the extent of an intracerebral hemorrhage which is crucial for patient treatment decisions. For hospitals and mobile stroke units on the front lines of patient assessment, Rapid Hyperdensity provides additional contextual data to help physicians make more informed triage and transfer decisions–getting patients to the right place more efficiently. “Rapid Hyperdensity helps physicians make the first of many critical decisions involved in head trauma and hemorrhagic stroke protocol. As the only comprehensive neurovascular decision support platform to offer this functionality, RapidAI aims to alleviate the enormous pressure of determining the best next course of action , ” said Karim Karti, CEO of RapidAI. “This FDA clearance is a symbol of RapidAI’s ongoing commitment to push the boundaries of neurovascular care, while designing every product with physicians first in mind.” The key benefits of Rapid Hyperdensity include: Automated detection of intracranial hyperdensities >1ml Quick identification of hyperdense volumes to improve hemorrhage management Fast results that can be viewed via the Rapid mobile app, PACS/Workstation, or email "As a neurosurgeon who treats many patients with intracranial hemorrhage (ICH), I am very excited for the recently approved Rapid Hyperdensity product that builds on the well-established RapidAI stroke platform,” said Dr. Alejandro M. Spiotta, director of the Neuroendovascular Surgery Division at the Medical University of South Carolina. “Detection of ICH via AI can save lives by helping to speed up diagnosis and accelerate transfer to the best physician and hospital that can take care of the patient. With the addition of automatic hyperdense volume measurement, physicians can more easily track volume over time and help quickly identify which patients may require an intervention. This is an exciting time for those of us treating ICH." To learn more about how RapidAI is transforming stroke care, please visit: https://www.rapidai.com/stroke About RapidAI RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Empowering physicians to make faster decisions for better patient outcomes, RapidAI is leading the next evolution of clinical decision-making and patient workflow. Based on intelligence gained from over 5 million scans in more than 2,000 hospitals in over 60 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible. RapidAI – where AI meets patient care.

Contact PR

Jessica Stebing

Jessica Stebing

Group Manager, Marketing Communications

stebing@rapidai.com

Get to know Rapid in the real world

View All Resources
Video - Lumina Webinar Replay

Webinar

The end of manual head & neck reconstructions // A faster path with Lumina 3D

In this webinar, we focus on the challenges and opportunities in 3D head and neck CTA reconstruction workflows. Our speakers share real-world insights on how the Lumina 3D platform can have a tangible impact on CT workflow, scanner throughput, and diagnosis.
Radiology Rewired Podcast - Episode 1 Thumbnail

Podcast

AI Meets Imaging | Radiology Rewired | Ep. 1

In the debut episode of Radiology Rewired, RapidAI’s new clinician-led podcast hosted by Dr. Singh, Dr. Greg Albers—founder of RapidAI and professor of neurology at Stanford University—shares the story behind one of medicine’s most important breakthroughs: extending the stroke treatment window to 24 hours. Dr. Albers recounts how decades of imaging research led from early diffusion-perfusion MRI to automated AI tools that changed global stroke guidelines and transformed how teams diagnose and treat patients. This episode explores how deep clinical AI is reshaping radiology and why credible, clinician-led innovation remains essential for the next generation of healthcare technology.
Resources - multistakeholder white paper

White paper

The clinical AI champion's guide: getting to "yes" in complex health systems

This guide is designed for internal champions, clinicians, service line leaders, and administrators who believe in the potential of AI to improve care and operations. It offers practical insights from a C-suite advisory panel from leading health systems across the nation on how decisions are made, who typically drives them forward, and what tools and strategies are proving most effective in securing alignment and buy-in across the system.